Resources

 ## Breadcrumb

1. [Home](/)
2. [Resources](/resources/resource-center)
3. [Resource Center](/resources/resource-center)
 
  

 

 

# Case Study: Value Drug Company | DSCSA Product Investigation—A Compliance Solution

 

 

 

 

 

 ![banner-image](https://www.tracelink.com/sites/default/files/_global-asset/images/insights/futurelink-nashville-vdc-poster.png) 

 

 

 

 

- [Download PDF](/node/16276/pdf)
- [Share](#)
    - [ LinkedIn ](https://www.linkedin.com/shareArticle?mini=true&url=https://www.tracelink.com/resources/resource-center/case-study-value-drug-company-dscsa-product-investigation8212a-compliance-solution&title=Case Study: Value Drug Company | DSCSA Product Investigation—A Compliance Solution&summary=See how Value Drug Company standardized the process for illegitimate and suspect product investigations for DSCSA compliance.&source=TraceLink "LinkedIn")
    - [ Facebook ](https://www.facebook.com/share.php?u=https://www.tracelink.com/resources/resource-center/case-study-value-drug-company-dscsa-product-investigation8212a-compliance-solution&t=Case Study: Value Drug Company | DSCSA Product Investigation—A Compliance Solution "Facebook")
    - [ Mail ](mailto:?subject=Case Study: Value Drug Company | DSCSA Product Investigation—A Compliance Solution+|+TraceLink&body=https://www.tracelink.com/resources/resource-center/case-study-value-drug-company-dscsa-product-investigation8212a-compliance-solution "Mail")
    - [ Twitter ](https://twitter.com/intent/tweet?text=Case Study: Value Drug Company | DSCSA Product Investigation—A Compliance Solution https://www.tracelink.com/resources/resource-center/case-study-value-drug-company-dscsa-product-investigation8212a-compliance-solution&via=TraceLink "Twitter")
 
 

 

 

 

 

#### Table of contents

 

 

 

Suspect and illegitimate product investigations can result in miscommunication with trade partners and record keeping problems—but Value Drug Company has the answer. Watch this FutureLink Nashville video and read the case study poster to learn how Value Drug Company is partnering with TraceLink to implement a formalized solution to standardize the process and provide the results of investigations to authorities when requested.

![](https://play.vidyard.com/qjYkar9r4PrPwNPFWnpZrR.jpg)

![Value Drug Company Poster](/sites/default/files/_global-asset/images/insights/futurelink-nashville-vdc-poster.png)



 



 

[Case Study](/category/case-study)[DSCSA for Manufacturers](/category/dscsa-manufacturers)[Regulatory/Compliance](/category/regulatory-compliance)[United States](/region-type/united-states) 

 

 

 

#### Table of contents

 

 

 

 Subscribe to Agile Supply Chain Insights

 

Subscribe to stay informed with the latest patient-centric agile supply chain thought leadership content. 



 

 

 

 

 

 

 

 

 

 

##### More Serialization and Compliance Case Studies

 

 [ ![futurelink-nashville-sharp-poster.png](https://www.tracelink.com/sites/default/files/styles/resize_image_style_640_480/public/_global-asset/images/insights/futurelink-nashville-sharp-poster.png.webp?itok=Lq79ocrD) ](/resources/resource-center/case-study-sharp-packaging-services-epcis-connection-changes-post-golive) 

#####  Case Study: Sharp Packaging Services | EPCIS Connection Changes Post Go-Live 

 See how Sharp Packaging Services overcame EPCIS change management challenges in the pharma supply chain with TraceLink's help. 

 

 [View More](/resources/resource-center/case-study-sharp-packaging-services-epcis-connection-changes-post-golive) 

 

 [ ![futurelink-nashville-cpl-poster.png](https://www.tracelink.com/sites/default/files/styles/resize_image_style_640_480/public/_global-asset/images/insights/futurelink-nashville-cpl-poster.png.webp?itok=dYxB92x-) ](/resources/resource-center/case-study-cpl-the-cmo-serialization-perspective8212utilizing-a-standardized-approach-for-efficient-partner-onboarding) 

#####  Case Study: CPL | The CMO Serialization Perspective—Utilizing a Standardized Approach for Efficient Partner Onboarding 

 See how contract manufacturer Contract Pharmaceuticals Limited implemented a 3-step process for smooth pharmaceutical partner onboarding. 

 

 [View More](/resources/resource-center/case-study-cpl-the-cmo-serialization-perspective8212utilizing-a-standardized-approach-for-efficient-partner-onboarding) 

 

 [ ![futurelink-nashville-noden-pharma-poster.png](https://www.tracelink.com/sites/default/files/styles/resize_image_style_640_480/public/_global-asset/images/insights/futurelink-nashville-noden-pharma-poster.png.webp?itok=N3HnbRyt) ](/resources/resource-center/case-study-noden-pharma-the-cost-of-noncompliance) 

#####  Case Study: Noden Pharma | The Cost of Non-Compliance 

 See how global pharmaceuticals company Noden Pharma avoided the financial and operational risks of DSCSA noncompliance. 

 

 [View More](/resources/resource-center/case-study-noden-pharma-the-cost-of-noncompliance)